Cargando…
Metabolic changes associated with adaptive resistance to daptomycin in Streptococcus mitis-oralis
BACKGROUND: Viridans group streptococci of the Streptococcus mitis-oralis subgroup are important endovascular pathogens. They can rapidly develop high-level and durable non-susceptibility to daptomycin both in vitro and in vivo upon exposure to daptomycin. Two consistent genetic adaptations associat...
Autores principales: | Parrett, Allison, Reed, Joseph M., Gardner, Stewart G., Mishra, Nagendra N., Bayer, Arnold S., Powers, Robert, Somerville, Greg A. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7296729/ https://www.ncbi.nlm.nih.gov/pubmed/32539684 http://dx.doi.org/10.1186/s12866-020-01849-w |
Ejemplares similares
-
614. Metabolic Interventions for the Resensitization of Daptomycin-Resistant (DAP-R) Streptococcus mitis-oralis Strains to DAP In vitro and Ex Vivo in a Simulated Model of Experimental Endocarditis (IE)
por: Somerville, Greg, et al.
Publicado: (2019) -
Strain-Specific Adaptations of Streptococcus mitis-oralis to Serial In Vitro Passage in Daptomycin (DAP): Genotypic and Phenotypic Characteristics
por: Mishra, Nagendra N., et al.
Publicado: (2020) -
Mechanistic Fingerprinting Reveals Kinetic Signatures of Resistance to Daptomycin and Host Defense Peptides in Streptococcus mitis-oralis
por: Yeaman, Michael R., et al.
Publicado: (2021) -
1703. Efficacy of Selected Metabolic Inhibitors for the Prevention and Resensitization of High-Level Daptomycin Resistance in Streptococcus mitis-oralis In Vitro and in an Ex Vivo Simulated Endocarditis Model
por: Kebriaei, Razieh, et al.
Publicado: (2022) -
Activity of the Lactate Dehydrogenase Inhibitor Oxamic Acid against the Fermentative Bacterium Streptococcus mitis/oralis: Bactericidal Effects and Prevention of Daptomycin Resistance In Vitro and in an Ex Vivo Model
por: Kebriaei, Razieh, et al.
Publicado: (2022)